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Abstract
Notch receptors are important mediators of cell fate during embryogenesis, but their role in adult
physiology, particularly in postnatal angiogenesis, remains unknown. Of the Notch receptors, only
Notch1 and Notch4 are expressed in vascular endothelial cells. Here we show that blood flow
recovery and postnatal neovascularization in response to hindlimb ischemia in haploinsufficient
global or endothelial-specific Notch1+/- mice, but not Notch4-/- mice, were impaired compared with
wild-type mice. The expression of vascular endothelial growth factor (VEGF) in response to ischemia
was comparable between wild-type and Notch mutant mice, suggesting that Notch1 is downstream
of VEGF signaling. Treatment of endothelial cells with VEGF increases presenilin proteolytic
processing, γ-secretase activity, Notch1 cleavage, and Hes-1 (hairy enhancer of split homolog-1)
expression, all of which were blocked by treating endothelial cells with inhibitors of
phosphatidylinositol 3-kinase/protein kinase Akt or infecting endothelial cells with a dominant-
negative Akt mutant. Indeed, inhibition of γ-secretase activity leads to decreased angiogenesis and
inhibits VEGF-induced endothelial cell proliferation, migration, and survival. Overexpression of the
active Notch1 intercellular domain rescued the inhibitory effects of γ-secretase inhibitors on VEGF-
induced angiogenesis. These findings indicate that the phosphatidylinositol 3-kinase/Akt pathway
mediates γ-secretase and Notch1 activation by VEGF and that Notch1 is critical for VEGF-induced
postnatal angiogenesis. These results suggest that Notch1 may be a novel therapeutic target for
improving angiogenic response and blood flow recovery in ischemic limbs.
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Notch receptors are transmembrane receptors that interact with membrane-bound ligands,
Delta and Serrate/Jagged.1 Ligand binding induces proteolytic cleavage of Notch and
subsequent nuclear translocation of the Notch intracellular domain (NICD),2 where it interacts
with RBP-J protein, and the complex functions as a transcription factor for downstream target
Correspondence to Dr James K. Liao, Brigham & Women’s Hospital, 65 Landsdowne St, Rm 275, Cambridge, MA 02139. E-mail
jliao@rics.bwh.harvard.edu.
This manuscript was sent to Donald D. Heistad, Consulting Editor, for review by expert referees, editorial decision, and final disposition.
Disclosures
None.
NIH Public Access
Author Manuscript
Circ Res. Author manuscript; available in PMC 2009 January 9.
Published in final edited form as:
Circ Res. 2007 January 5; 100(1): 70–78. doi:10.1161/01.RES.0000254788.47304.6e.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
genes such as Hes-1 (hairy enhancer of split homolog-1).3 Recent studies suggest that Notch
signaling plays a critical role in embryonic development through cell fate determination.4-6
In particular, the loss of Notch1 or haploinsufficiency of the Notch ligand Dll4 leads to impaired
vascular development and somitogenesis, enhanced apoptosis of endothelial cells in the
placenta and yolk sac, and embryonic lethality.5,7,8 Thus, Notch1 is essential for angiogenic
vascular remodeling and embryonic development.
Of the Notch receptors, the vascular endothelium expresses only Notch1 and Notch4.9
Endothelial-specific Notch1-/- mice exhibit a similar phenotype to global Notch1-/- mice,
suggesting that endothelial Notch1 is critical for embryonic vascular development and
viability.7,10 In contrast, Notch4-/- mice are viable without any observable vascular defects.
However, Notch1-/-/Notch4-/- mice exhibit a more severe vascular phenotype than Notch1-/-
mice, suggesting that Notch1 and Notch4 may have overlapping roles in vascular remodeling
and morphogenesis during development.5 The role of Notch1 and Notch4 signaling in postnatal
vascular angiogenesis and remodeling remains to be determined.
Postnatal angiogenesis or neovascularization in response to hypoxia, limb ischemia, or wound
healing is mediated, in part, by vascular endothelial growth factor (VEGF). VEGF is
upregulated in response to hypoxia11 and promotes angiogenesis in ischemic tissues.12
Although VEGF also increases the expression of Notch receptors and their ligands, it is not
known whether Notch receptors are necessary for VEGF-mediated angiogenic response.13
The purpose of this study was to determine whether Notch1 and/or Notch4 are essential for
postnatal angiogenesis and, if so, to determine the signaling pathway(s) that leads to Notch
cleavage and signaling in vascular endothelial cells.
Materials and Methods
Animals
N1+/-, N4-/-, and wild-type (WT) mice were generated as described.5,14 The ecN1+/- mice
were generated by crossing Notch1+/flox and Tie2-Cre transgenic mice (Tie2Cre+/-).7 All of
the animals used for the experiments were 10-week-old male mice on pure C57Bl/6
background. All experimental protocols were approved by the Standing Committee on Animal
Care at Harvard and Tufts Medical School (Boston, Mass).
Immunohistochemistry
Immunohistochemistry was performed on the thigh adductor muscle using standard protocol
(see expanded Materials and Methods section in the online data supplement, available at
http://circres.ahajournals.org).
Isolation of Murine Endothelial Cells
Isolation of endothelial cells from the lungs and hearts of WT, N1+/-, ecN1+/-, and N4-/- mice
was performed using 2-sorting with antibody-coated magnetic beads (Dynal beads coated with
antibodies for platelet endothelial cell adhesion molecule (PECAM)-1 and intercellular
adhesion molecule-2. (See the online data supplement.)
Cell Culture and Gene Transfer
Human umbilical endothelial cells (HUVECs) and bovine aortic endothelial cells (BAECs)
were cultured as described (see the online data supplement). HUVECs were infected with
Ad.caAkt (myr-Akt), Ad.dn-Akt (AAA-Akt) (provided by Kenneth Walsh, Boston University,
Mass), Ad.NICD containing GFP reporter (provided by Ken-ichi Tezuka, Gifu University,
Japan), or Ad.GFP.
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Hindlimb Ischemia Model
Hindlimb ischemia was achieved by extensive excision of the unilateral femoral artery under
anesthesia as described.15 Blood flow was monitored with a laser Doppler blood flow (LDBF)
analyzer (Moor LDI; Moor Instruments) before and on postoperative days 0, 7, 14, 21, and 28,
as described. To control for data variations caused by ambient light and temperature, LDBF
was expressed as the ratio of ischemic to nonischemic (contralateral) limb.
Measurements of Capillary Density
Capillary density in the thigh adductor skeletal muscles was analyzed 28 days after femoral
artery excision. Three pieces of ischemic muscles were harvested from each animal, sliced,
and fixed in 4% paraformaldehyde. Capillary endothelial cells were identified by
immunohistochemical staining with biotinylated isolectinB4 antibody (Vector Laboratories).
16 Fifteen random microscopic fields from 3 different sections per mouse were examined.
Capillary density was expressed as the number of capillaries per high-power field (hpf)
(magnification, ×400).
Assay for γ-Secretase Activity
The assay for γ-secretase activity was performed as described.17 Briefly, solubilized membrane
preparations were incubated with 8 μmol/L intramolecularly quenched fluorogenic peptide
probe harboring the substrate for γ-secretase (Peptode International Inc). Fluorescence was
measured using a plate reader (SPECTRA Fluor, TECAM) with excitation wavelength at 355
nm and emission wavelength at 440 nm.
Cell Proliferation, Adhesion, and Migration Assays
Cell-proliferation assay was performed as described.18 The number of cells stained with crystal
violet was quantified by measurement of absorbance at 590 nm with a microplate reader
(SPECTRA Fluor, TECAM). Cellular DNA synthesis was assessed by [3H]-thymidine uptake
as described.19 Cell adhesion assay was performed as described.20 Cell migration was
estimated in a modified Boyden chamber (Neuro Probe) with a gelatin-coated 8-μm-pore
polycarbonate filter as described.20 Annexin V staining was used for assessment of apoptotic
cells. All protocols are available as in the online data supplement.
Assessment of Tube Formation
Endothelial cells were infected with Ad.GFP or Ad.NICD at MOI of 50 for 24 hours. Cells
were seeded on Matrigel-coated plates at a density of 2×104 cells per well in medium 199 with
1% FBS with and without VEGF and/or N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-
phenylglycine t-butyl ester (DAPT) and then incubated for 18 hours at 37°C. Photomicrographs
were taken at ×40 magnification. Total tube length was measured using the NIH Image program
and expressed as percentage of control (Ad.GFP).
Endothelial Explant Assay
An ex vivo angiogenesis assay was performed as described (see the online data supplement).
21 The greatest distance from the aortic ring body to the end of the vascular sprouts (sprout
length) was measured by NIH Image program at 3 distinct points per ring and in 3 different
rings per treatment group.22 Results are expressed in arbitrary units (1 U represents 40 pixels
per millimeter).
Statistics
All values are expressed as mean±SD. Differences among 3 groups were analyzed by 1-way
ANOVA followed by Scheffe’s comparison for 2 groups. The comparative incidence of limb
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amputation was evaluated by χ2 test. A probability value of <0.05 was taken to be significant
difference.
Results
Notch1 Mediates Blood Flow Recovery and Angiogenesis Following Ischemia
To determine the role of Notch1 and Notch4 in postnatal angiogenesis, we subjected WT,
heterozygous Notch1 KO (N1+/-), heterozygous endothelial-specific Notch1 KO (ecN1+/-),
and homozygous Notch4 KO (N4-/-) mice to hindlimb ischemia. The expression of Notch1 in
endothelial cells of N1+/- or ecN1+/- mice was approximately half of that of WT and N4-/- mice
(data not shown). There were no observable differences in appearance, body weight, or heart
rate between WT and these mutant Notch mice, either before, during, or after hindlimb
ischemia. The N4-/- mice, however, exhibited a slightly higher systolic blood pressure
compared with WT mice (116±6 mm Hg versus 110±5 mm Hg, P<0.05; n=12 in each group).
All of the mice survived hindlimb ischemia surgery, and their phenotypes with respect to limb
ischemia were analyzed.
Following hindlimb ischemia, the expression of VEGF in the ischemic adductor muscles was
induced diffusely at 7 days, and the level of expression was comparable between WT and Notch
mutant mice (Figure 1A). Despite comparable levels of VEGF, distal limb necrosis at 28 days
was observed in 4% of WT mice, 42% of N1+/- mice, and 50% of ecN1+/- mice (Figure 1B).
Distal limb necrosis at 28 days occurred in 6% of N4-/- mice (data not shown), which is
comparable to that of WT mice. These findings indicate that increased distal limb necrosis
following hindlimb ischemia in N1+/- and ecN1+/- mice was not attributable to differences in
VEGF upregulation and that Notch1 rather than Notch4 protects against ischemia-induced limb
necrosis.
Basal and postischemic blood flows as measured by LDBF imaging were comparable between
mice from each group. Compared with the nonischemic limb (control), blood flow recovery
to the ischemic limb at 14 and 28 days was also comparable between WT and N4-/- mice (ratio
of ischemic to control limb: 0.92±0.08 and 0.93±0.08, respectively, P=NS) (Figure 2A). These
findings indicate that Notch4 does not contribute to blood flow recovery in response to
ischemia. In contrast, blood flow recovery in N1+/- and ecN1+/- mice was substantially impaired
at 14 days and remained impaired at 28 days (ratio of ischemic to control limb: 0.47±0.12 and
0.40±0.15, respectively, P<0.0001 compared WT; n=12 for each at 28 d). These results indicate
that endothelial Notch1 is critical to blood flow recovery in response to ischemia.
The improvement in blood flow recovery corresponded to increased tissue capillary density
(Figure 2B). The capillary densities in the nonischemic adductor muscles (control) were
comparable between WT and Notch mutant mice (WT, 58±5; N1+/-, 58±7; ecN+/-, 56±5; and
N4-/-, 57±5 capillaries per hpf; P=NS for all compared with WT). Furthermore, following
hindlimb ischemia, the capillary density per hpf (×400 magnification) in the ischemic adductor
muscles of WT and N4-/- mice were increased to a comparable extent compared with that of
control nonischemic capillary density (102±11 and 101±11 capillaries per hpf, respectively;
P<0.001 compared with control for both; P=NS between WT and N4-/- mice). However, the
capillary densities in the ischemic adductor muscles of N1+/- and ecN1+/- mice were
substantially lower (70±7.8 and 68±7.9 capillaries per hpf, respectively, P<0.001 compared
with WT; n=8 for each at 28 days). These findings indicate that Notch1, but not Notch4, is
critical for the post-ischemic angiogenic response.
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Induction of Endothelial Notch1 Expression and Signaling in Ischemic Limb
The expression of Notch1 in control limbs was barely detectable despite presence of
PECAM-1-stained endothelial cells. However, following ischemia, Notch1 was expressed in
some endothelial cells of ischemic limbs on day 7 (Figure 3A). This corresponded to increased
Hes-1 expression in the endothelium of ischemic, but not control, limbs (Figure 3B). In
contrast, there was constitutive expression of Notch4 in the endothelium (ie, PECAM-1-
positive stained cells), which was comparable in control and ischemic limbs (data not shown).
Similarly, in aortas from WT mice, microvessel sprouting was 228±19 U (1 U=40 pixels per
millimeter on NIH Image program) (Figure 3C). However, the sprouting of microvessels from
the aortas of N1+/- and ecN1+/- mice was substantially reduced (45±6 and 56±6 U, respectively,
P<0.01 for both compared with WT). These findings indicate that ischemia induces the
expression and activation of Notch1 and that Notch1 mediates microvessel sprouting.
Akt Mediates VEGF-Induced Notch1 Cleavage and Activation
Treatment of endothelial cells with VEGF (25 ng/mL) increased Akt phosphorylation within
15 to 30 minutes (Figure 4A). This corresponded with the temporal cleavage of Notch1 and
expression of Hes-1. VEGF, however, did not alter the expression of Akt, the Notch ligand,
Jagged-1, or Notch1. Cotreatment with the phosphatidylinositol 3-kinase (PI3K) inhibitor
LY294002 or the Akt inhibitor SH-5 inhibited VEGF-induced Akt activation, Notch1 cleavage,
and Hes-1 expression (Figure 4B). Interestingly, the NOS inhibitor NG-nitro-L-arginine methyl
ester partially decreased VEGF-induced Akt phosphorylation but had little or no effect on
VEGF-induced Notch1 activation. In contrast, the γ-secretase inhibitor DAPT had no effect
on VEGF-induced Akt phosphorylation but completely blocked VEGF-induced Notch1
cleavage and Hes-1 expression. These findings suggest that γ-secretase mediates Notch1
cleavage and activation by Akt.
To verify that Akt mediates Notch1 activation, endothelial cells were infected with adenovirus
carrying empty vector (control, Ad.GFP), dominant-negative Akt mutant (Ad.dnAkt), or
constitutively active Akt mutant (Ad.caAkt) in the presence or absence of VEGF stimulation
(Figure 4C). In endothelial cells infected with Ad.GFP, VEGF increased Akt and glycogen
synthase kinase (GSK)-3 phosphorylation, Notch1 cleavage, and Hes-1 expression. In contrast,
in endothelial cells infected with Ad.dnAkt, VEGF was unable to activate Akt or Notch1.
Infection with Ad.caAkt alone increased Akt and GSK-3 phosphorylation as well as induced
Notch1 cleavage and Hes-1 expression. These results indicate that Akt mediates VEGF-
induced Notch1 cleavage and activation.
Activation of γ-Secretase by Akt Mediates VEGF-Induced Notch1 Cleavage
Treatment with either LY294002 or SH-5 decreased γ-secretase activity below basal levels and
completely blocked VEGF-induced γ-secretase activity (Figure 5A). Indeed, the activation of
γ-secretase by VEGF was inhibited in a concentration-dependent manner by the γ-secretase
inhibitor DAPT (Figure 5B). Interestingly, endogenous γ-secretase activity was also partially
inhibited by DAPT (81±4% and 62±8% of control for 2 and 20 μmol/L of DAPT, respectively,
P<0.05 compared with control for both), suggesting that ≤20 μmol/L DAPT is incapable of
inhibiting a substantial amount of basal γ-secretase activity. The increase in VEGF-induced γ-
secretase activity corresponded with increase in Notch1 cleavage, which was blocked by DAPT
(IC50≈5 μmol/L) (Figure 5C).
Because the activation of γ-secretase involves the proteolytic cleavage of 1 of its core
components, presenilin, we investigated whether Akt mediates presenilin proteolytic
processing by VEGF. Treatment with VEGF enhanced the cleavage of presenilin from the
holoenzyme (55 kDa) to the C-terminal fragment (22 kDa) (Figure 5D). Infection of endothelial
cells with Ad.dnAkt blocked VEGF-induced proteolytic cleavage of presenilin, whereas
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infection of endothelial cells with Ad.caAkt increased presenilin proteolytic cleavage. These
findings indicate that PI3K/Akt pathway mediates the activation of γ-secretase and Notch1 by
VEGF in endothelial cells.
Notch1 Mediates VEGF-Induced Endothelial Cell Proliferation and Migration
In the absence of VEGF stimulation, treatment with DAPT did not affect endothelial cell
proliferation as determined by cell number and DNA synthesis ([3H]-thymidine incorporation)
(Figure 6A and 6B). These findings suggest that basal γ-secretase activity, which is inhibited
partially by DAPT, does not mediate endothelial cell proliferation. Treatment with VEGF
produced a 2-fold increase in cell number (5620±150 to 9990±310 cells, P<0.01) and [3H]-
thymidine incorporation (6370±290 to 12400±590 cpm/well, P<0.01). Cotreatment with
DAPT (2 and 20 μmol/L) inhibited VEGF-induced endothelial cell proliferation by 58% and
71%, respectively (P<0.001 for both compared with VEGF alone). These findings suggest that
γ-secretase contributes to VEGF-induced endothelial cell proliferation.
Similarly, basal adhesion and migration in a modified Boyden chamber were not affected by
inhibition of basal γ-secretase activity with DAPT (Figure 6C and 6D). Treatment with VEGF
produced a 2- to 3-fold increase in cell adhesion (5,620±150 to 9990±310 cells, P<0.01) and
migration (100±3% to 280±15%, P<0.01). Cotreatment with DAPT inhibited endothelial cell
adhesion and migration in a concentration-dependent manner. These findings indicate that
VEGF-induced increase in γ-secretase activity contributes to endothelial cell adhesion and
migration.
Notch1 Mediates the Antiapoptotic Effects of VEGF on Endothelial Cells
To determine whether Notch1 plays an antiapoptotic role in endothelial cells, apoptosis, as
determined by the presence of cleaved nuclei by DAPI staining and expression of Annexin V,
was assessed in endothelial cells exposed to serum deprivation. Following 16 hours of serum
deprivation, approximately 15% to 17% of endothelial cells undergo apoptosis, which was
unaffected by treatment with DAPT (Figure 7A). Treatment with VEGF improved endothelial
cell survival and decreased the number of apoptotic cells from 16.4% to 1.8% of total cells
(P<0.01). However, cotreatment with DAPT (2 and 20 μmol/L) reversed the protective effects
of VEGF and increased the number of apoptotic cells from 1.8% to 8.1% and 14.2% of total
cells, respectively (P<0.01 for both compared with VEGF alone). Similarly, cleaved caspase3,
an indicator of the apoptotic process, was present in endothelial cells deprived of serum (Figure
7B). Treatment with VEGF decreased the amount of cleaved caspase3, suggesting decreased
apoptosis. In a concentration-dependent manner, cotreatment with DAPT blocked VEGF-
induced decrease in caspase3 cleavage. These findings suggest that Notch1 signaling mediates
the antiapoptotic effects of VEGF on endothelial cells.
Notch1 Mediates VEGF-Induced Angiogenesis
Matrigel-based in vitro angiogenesis assay was performed to determine whether Notch1
contributes to VEGF-induced angiogenesis. Under basal conditions, endothelial cells infected
with Ad.GFP formed tubular networks, the lengths of which were increased substantially
following exposure to VEGF (183±6% versus 100±5%, P<0.01 compared with Ad.GFP)
(Figure 7C and 7D). Cotreatment with DAPT blocked VEGF-induced tubular networks by
75% (121±4% of Ad.GFP, P<0.05 compared with Ad.GFP+VEGF). Infection of endothelial
cells that have been treated with VEGF and DAPT with an adenovirus containing the Notch
intracellular domain (Ad.NICD) reversed the inhibitory effect of DAPT on VEGF-induced
tube formation (160±7% of Ad.GFP, P<0.05 compared with VEGF+DAPT). These results
indicate that Notch1 mediates VEGF-induced angiogenesis.
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Discussion
Members of the Notch receptor family are highly conserved type I transmembrane receptors
that determine cell fate in embryogenesis.6 What has not been clearly established is the role
of Notch receptors in postnatal physiology. In this study, we have shown that endothelial
Notch1 plays a critical role in vascular remodeling by mediating the VEGF-induced angiogenic
response to limb ischemia. We found that Notch1 contributes to VEGF-induced endothelial
cell proliferation, migration, and survival. Furthermore, the loss of Notch1 in the endothelium,
as opposed to the loss of Notch1 in other cell types, was primarily responsible for the impaired
angiogenic response as blood flow recovery and capillary densities were comparably reduced
in endothelial-specific ecN1+/- and global N1+/- mice. Although Notch4 is also expressed in
endothelial cells,9 Notch4 does not appear to be necessary for postnatal angiogenesis as both
limb necrosis and blood flow recovery in Notch4-/- mice were similar to that of WT mice. Our
results, therefore, indicate that impairment of endothelial Notch1 worsens the severity of limb
ischemia with respect to tissue necrosis and suggest that agents or conditions, which improve
endothelial Notch1 signaling, may be beneficial in contributing to therapeutic angiogenesis.
Growth factors such as VEGF, hepatic growth factor (HGF), and fibroblast growth factor (FGF)
are upregulated in ischemic tissues, leading to increased angiogenesis and improved blood
flow. VEGF is critical for vascular development and neovascularization, and VEGF-deficient
mice exhibit impaired angiogenesis following limb ischemia.23 However, the differences in
angiogenesis and blood flow recovery between WT mice and Notch1 mutant mice in our study
could not be attributed to increases in VEGF expression, because VEGF in the ischemic skeletal
muscle was similar between the different groups of mice. These findings suggest that Notch1
must lie downstream of VEGF signaling. This relationship between VEGF and Notch1 is
consistent across different cell types and species. For example, in zebrafish, VEGF, which acts
downstream of sonic hedgehog, regulate arterial cell fate determination through the Notch
pathway.4 VEGF also activates other downstream signaling molecules including
phospholipase C-γ, Src, p38MAPK, Ras, Raf, FAK, and PI3K/Akt, leading to endothelial cell
proliferation, migration, and survival.24 In particular, the activation of Akt in endothelial cells
leads to cell survival, proliferation, migration, nitric oxide production, and microvascular tube
formation in response to VEGF stimulation.25 Thus, Notch1 signaling could contribute to
many of the Akt-mediated effects of VEGF. Indeed, we found that Notch1 expression on the
endothelium was induced following ischemic injury and that VEGF-induces Notch1 cleavage
and signaling through an Akt-dependent mechanism (Figure 8). Taken together, these findings
suggest that Notch1 is an important downstream target of VEGF in vascular endothelial cells.
The Notch receptors are activated when bound to ligands belonging to the Delta or Serrate/
Jagged family.1 Ligand-bound Notch receptors are proteolytically cleaved at their
intramembrane site,26 resulting in the translocation of the Notch intracellular domain (NICD)
into the nucleus. Indeed, mutant mice, which cannot cleave Notch1, exhibit a similar phenotype
and embryonic lethality as Notch1-deficient mice.27 The NICD interacts with DNA-binding
proteins including RBP-Jκ, Su(H), and Lag-1, and the multiprotein complex regulates
transcription of target genes such as Hes-1 that are involved in cell fate determination.28 Hes-1
is a basic helix-loop-helix protein, which is essential for neurogenesis, myogenesis,
hematopoiesis, self-renewal of neural stem cells, and angiogenesis. How Notch signaling
regulates angiogenesis remains to be determined. However, recent studies suggest that
endothelial Notch signaling upregulates the expression of Ephrin-B229 and Ephrin-B2 is
required for directional migration and cell-matrix interaction.30 Furthermore, Notch may
regulate angiogenesis through effects on Hey2/CHF1. Gridlock, the homolog of Hey2/CHF1
in zebrafish, is thought to be downstream of Notch signaling and is involved in arterio-venous
differentiation. Thus, although the precise mechanism by which Notch1 regulates angiogenesis
is not known, it is likely that several downstream targets mediate this process.
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The multiprotein enzyme complex γ-secretase, which includes presenilin, nicastrin, Aph-1,
and Pen-2, cleaves Notch receptors.26 The regulation of presenilin, which comprises the active
catalytic core of γ-secretase, is still relatively unknown. Besides Notch receptors, γ-secretase
is also required for the proteolytic processing of Alzheimer’s disease β-amyloid precursor
protein.31 Thus, γ-secretase is an important regulator of both neurogenesis and
neuropathobiology. However, the relationship between Notch receptors and Alzheimer’s
disease remains to be determined. Presenilin is a 55-kDa aspartyl protease that is also
proteolytically cleaved to yield amino- and carboxy-terminal fragments of ≈35 kDa and ≈20
kDa, respectively.32 The proteolytic processing of presenilin is required for its maturation and
activation of γ-secretase activity.33 In agreement with these results, we find that Akt mediates
VEGF-induced Notch1 signaling via proteolytic processing of presenilin and subsequent
activation of γ-secretase. Interestingly, GSK-3, which interacts with presenilin and is also a
downstream target of Akt, has been shown to modulate β-amyloid precursor protein cleavage.
34
In this study, the physiological relevance of endothelial Notch1 in postnatal neovascularization
is demonstrated by the impaired angiogenic response in ecN1+/- mice and the inhibition of
VEGF-induced endothelial cell proliferation, migration, and survival by the γ-secretase
inhibitor DAPT. Although relatively little is known about the regulation and function of
endothelial γ-secretase, a recent study showed that capillary sprouting and vascular remodeling
are impaired in presenilin-deficient mice.35 Furthermore, DAPT has been shown to inhibit
endothelial proliferation and angiogenesis without cytotoxicity, leading to suppression of
tumor growth.36 Thus, γ-secretase and Notch1 signaling may be important downstream targets
of VEGF in terms of ischemia-induced neovascularization. These findings suggest that
modulation of γ-secretase activity and Notch1 signaling in the endothelium may be
therapeutically beneficial in patients with ischemic vascular disease.
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Figure 1.
Increase limb necrosis in Notch1 mutant mice. A, Expression of VEGF in control and ischemic
limbs at 7 days was determined by immunohistochemical staining (top) and immunoblot
analysis (bottom) of adductor muscle. Bar=25 μm. B, Photomicrographs of ischemic limb
showing distal necrosis at 28 days (top, arrows). The percentage distribution of distal necrosis
in WT, N1+/-, and ecN1+/- mice relative to the total number of mice in each group is shown
(bottom). All mice survived hindlimb ischemia surgery and were analyzed. *P<0.05 compared
with WT.
Takeshita et al. Page 11
Circ Res. Author manuscript; available in PMC 2009 January 9.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 2.
Impaired blood flow recovery and angiogenesis in Notch1 mutant mice. A, LBDF showing
low-perfusion signal (dark blue) in ischemic hindlimbs of N1+/- and ecN1+/- mice, whereas
high-perfusion signal (red to white) was observed in ischemic hindlimb of WT and N4-/- mice
(left). Quantitative analysis of blood flow recovery following femoral artery ligation expressed
as ischemic to control LDBF ratio in WT, N1+/-, ecN1+/-, and N4-/- mice (right). *P<0.0001,
n=12 in each group. B, Isolectin B4 staining (brown-red color) of control (nonischemic) and
ischemic adductor muscle tissues from hindlimbs of WT and Notch1 mutant mice (left). The
photomicrographs are representative data from 8 individual mice from each group. Bar=25
μm. Quantitative analysis of capillary density (6 randomly selected fields from each slide; 3
slides per mice; 8 mice each) in WT and Notch1 mutant mice (number per hpf; ×400
magnification) (right). †P<0.001 compared with WT (nonischemic), *P<0.001 compared with
WT (ischemic).
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Figure 3.
Impaired microvessel sprouting in Notch1 mutant mice. A, Immunofluorescence staining for
Notch1 (green) and PECAM-1 (red) in skeletal muscle tissues from control and ischemic limbs
of WT mice at day7 after the procedure. B, Immunofluorescence staining for Hes-1 (green)
and PECAM-1 (red) in skeletal muscle tissues from control and ischemic limbs of WT mice
at day7 after the procedure. C, Representative fields (×40 magnification) showing microvessel
outgrowth in response to VEGF (50 ng/mL) from aortic explants of WT and Notch1 mutant
mice (left). Microvessel outgrowth is expressed quantitatively in arbitrary units (1 arbitrary
unit represents 40 pixels per millimeter) (right). Data are presented as mean±SD, n=8 in each
group. *P<0.001 for N1+/- and ecN1+/- compared with WT.
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Figure 4.
Akt mediates Notch1 cleavage and Hes-1 expression by VEGF. A, Immunoblots showing time
course of Akt and Notch1 activation and Notch1 ligand (Jagged-1) and Hes-1 expression in
HUVECs by VEGF (25 ng/mL) (top). Activation of Akt was assessed by Ser473
phosphorylation of Akt (p-Akt) relative to total Akt (t-Akt). Activation of Notch1 was
determined by the amount of cleaved Notch1 (c-Notch1) relative to total Notch1 (t-Notch1).
Densitometric analysis showing time course of Akt activation (p-Akt/t-Akt), Notch1 activation
(c-Notch1/t-Notch1), and Hes-1 expression by VEGF (bottom). Results are presented from 3
independent experiments. *P<0.05 compared with control (0 time point). B, Effects of PI3K
inhibitor LY294002 (LY, 10 μmol/L), Akt inhibitor SH-5 (10 μmol/L), NOS inhibitor NG-
nitro-L-arginine methyl ester (LNAME) (1 mmol/L), and γ-secretase inhibitor DAPT (20 μmol/
L) on Akt activation (p-Akt), Notch1 cleavage (c-Notch1), and Hes-1 expression by VEGF
(50 ng/mL, 30 minutes). Experiments were performed 3 times with similar results. C,
Representative immunoblots showing Akt activation (p-Akt), GSK-3 phosphorylation (p-
GSK3), Notch cleavage (c-Notch1), and Hes-1 expression in HUVECs infected with
adenovirus carrying GFP (Ad.GFP), dominant-negative mutant form of Akt (Ad.dnAkt), and
constitutively active mutant form of Akt (Ad.caAkt), in the presence or absence of VEGF
stimulation (50 ng/mL, 30 minutes). Three independent experiments yielded similar results.
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Figure 5.
Akt mediates activation of γ-secretase by VEGF. A, Effect of LY294002 (LY) (10 μmol/L) or
SH-5 (10 μmol/L) on γ-secretase activity in HUVECs in the presence or absence of VEGF (50
ng/mL, 30 minutes). *P<0.05 compared with no treatment or VEGF alone. Results are
presented from 3 independent experiments. B, Concentration-dependent effects of DAPT (2
and 20 μmol/L) on VEGF-induced (50 ng/mL, 30 minutes) γ-secretase activity. *P<0.05
compared with no treatment or VEGF alone. Results are presented from 3 independent
experiments. C, Representative immunoblots showing the concentration-dependent effects of
DAPT (0 to 20 μmol/L) on VEGF-induced (50 ng/mL, 30 minutes) Notch1 cleavage (c-Notch1)
relative to total Notch1 (t-Notch1) (top). Densitometric analysis of Notch1 activation (c-
Notch1/t-Notch1) by VEGF in the presence of increasing concentrations of DAPT (bottom).
*P<0.05 compared with no DAPT. Results are presented from 3 independent experiments. D,
Representative immunoblot using C-terminal presenilin antibody showing proteolytic
processing of presenilin in HUVECs infected with Ad.GFP, Ad.dnAkt, and Ad.caAkt, in the
presence or absence of VEGF stimulation (50 ng/mL, 30 minutes). The protein band at 55 kDa
represents presenilin holoenzyme, whereas the 22 kDa band carboxyl-terminal fragment of
presenilin. Results are representative of 3 experiments.
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Figure 6.
γ-Secretase mediates endothelial cell proliferation, adhesion, and migration by VEGF.
Concentration-dependent effects of γ-secretase inhibitor DAPT (2 and 20 μmol/L) on
proliferation (A), [3H]-thymidine incorporation (B), adhesion (C), and migration (D) of BAECs
in the presence or absence of VEGF (25 ng/mL). *P<0.001 compared with absence of DAPT.
n=8 in each group.
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Figure 7.
γ-Secretase mediates endothelial cell survival and angiogenesis by VEGF. A, Concentration-
dependent effects of DAPT (2 and 20 μmol/L) on apoptosis of HUVECs in the presence or
absence of VEGF (25 ng/mL). Apoptosis was induced by serum starvation for 16 hour and
assessed by DAPI and annexin V staining. *P<0.01 compared with absence of VEGF. n=8 in
each group. B, Representative immunoblot showing the concentration-dependent effects of
DAPT (2 and 20 μmol/L) on cleavage of caspase3 (c-caspase3) relative to total caspase3 (t-
caspase3) in HUVECs in the presence or absence of VEGF (50 ng/mL). Three independent
experiments yielded similar results. C, Representative microscopic hpfs (×400 magnification)
showing Matrigel-based, capillary-like tube formation in HUVECs infected with adenovirus
carrying GFP (Ad.GFP) or Notch intracellular domain (Ad.NICD) in the presence or absence
of VEGF (50 ng/mL)±DAPT (20 μmol/L). D, Quantitative analysis of tube formation (tube
length) from 8 separate experiments. *P<0.01 compared with Ad.GFP; †P<0.01 compared
with Ad.GFP+VEGF+DAPT.
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Figure 8.
Schematic diagram of endothelial Notch1 signaling in ischemia-induced angiogenesis.
Proposed model of Notch1 signaling and angiogenesis following hindlimb ischemia. Akt
indicates protein kinase B/Akt; LY294002, PI3K inhibitor; SH5, Akt kinase inhibitor;
Ad.dnAkt, adenovirus containing dominantnegative Akt; Ad.caAkt, adenovirus containing
constitutively active Akt; Ad.NICD, adenovirus containing Notch intracellular domain.
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